Literature DB >> 12393558

Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis.

Koichi Akashi1, Xi He, Jie Chen, Hiromi Iwasaki, Chao Niu, Brooke Steenhard, Jiwang Zhang, Jeff Haug, Linheng Li.   

Abstract

Hematopoietic stem cells (HSCs) maintain hematopoiesis by giving rise to all types of blood cells. Recent reports suggest that HSCs also possess the potential to generate nonhematopoietic tissues. To evaluate the underlying mechanisms in the commitment of HSCs into multitissue and multihematopoietic lineages, we performed oligonucleotide array analyses targeting for prospectively purified HSCs, multipotent progenitors (MPPs), common lymphoid progenitors (CLPs), and common myeloid progenitors (CMPs). Here we show that HSCs coexpress multiple nonhematopoietic genes as well as hematopoietic genes; MPPs coexpress myeloid and lymphoid genes; CMPs coexpress myeloerythroid, but not lymphoid genes, whereas CLPs coexpress T-, B-, and natural killer-lymphoid, but not myeloid, genes. Thus, the stepwise decrease in transcriptional accessibility for multilineage-affiliated genes may represent progressive restriction of developmental potentials in early hematopoiesis. These data support the hypothesis that stem cells possess a wide-open chromatin structure to maintain their multipotentiality, which is progressively quenched as they go down a particular pathway of differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393558     DOI: 10.1182/blood-2002-06-1780

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  105 in total

1.  The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.

Authors:  Berthold Göttgens; Cyril Broccardo; Maria-Jose Sanchez; Sophie Deveaux; George Murphy; Joachim R Göthert; Ekaterini Kotsopoulou; Sarah Kinston; Liz Delaney; Sandie Piltz; Linda M Barton; Kathy Knezevic; Wendy N Erber; C Glenn Begley; Jonathan Frampton; Anthony R Green
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

2.  Stability and multiattractor dynamics of a toggle switch based on a two-stage model of stochastic gene expression.

Authors:  Michael Strasser; Fabian J Theis; Carsten Marr
Journal:  Biophys J       Date:  2012-01-03       Impact factor: 4.033

3.  The potential landscape of genetic circuits imposes the arrow of time in stem cell differentiation.

Authors:  Jin Wang; Li Xu; Erkang Wang; Sui Huang
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

Review 4.  Mechanisms of fate decision and lineage commitment during haematopoiesis.

Authors:  Ana Cvejic
Journal:  Immunol Cell Biol       Date:  2015-11-03       Impact factor: 5.126

Review 5.  Hematopoietic stem cell: self-renewal versus differentiation.

Authors:  Jun Seita; Irving L Weissman
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

Review 6.  Lineage promiscuous expression of transcription factors in normal hematopoiesis.

Authors:  Toshihiro Miyamoto; Koichi Akashi
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

Review 7.  Deconstructing stemness.

Authors:  Harald Mikkers; Jonas Frisén
Journal:  EMBO J       Date:  2005-07-21       Impact factor: 11.598

Review 8.  Systems approach to phagocyte production and activation: neutrophils and monocytes.

Authors:  Hrishikesh M Mehta; Taly Glaubach; Seth Joel Corey
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

9.  Classification of topological domains based on gene expression and regulation.

Authors:  Jingjing Zhao; Hongbo Shi; Nadav Ahituv
Journal:  Genome       Date:  2013-09-04       Impact factor: 2.166

10.  unc-3-dependent repression of specific motor neuron fates in Caenorhabditis elegans.

Authors:  Brinda Prasad; Ozgur Karakuzu; Randall R Reed; Scott Cameron
Journal:  Dev Biol       Date:  2008-09-09       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.